1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide

C137H161F8N45O17 — CID 163919616

IUPAC1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide
SMILESCC(=O)Nc1ccc(CCCCn2cc(C(=O)NCc3cc(C(C)(F)F)ccn3)nn2)nn1.CC(=O)Nc1ccc(CCCCn2cc(C(=O)NCc3cccc(OC(C)(F)F)c3)nn2)nn1.CC(F)(F)Oc1cccc(CNC(=O)c2cn(CCCCc3ccc(NC(=O)C4CC4)nn3)nn2)c1.CC(F)(F)c1ccnc(CNC(=O)c2cn(CCCCc3ccc(NC(=O)C4CC4)nn3)nn2)c1.CNC(=O)c1cn(CCCCc2ccc(NC(=O)Cc3cccc(N4CCOCC4)c3)nn2)nn1.CNC(=O)c1cn(CCCCc2ccc(NC(=O)Cc3cccc(OCCOC)c3)nn2)nn1
InChIInChI=1S/C24H27F2N7O3.C24H30N8O3.C23H26F2N8O2.C23H29N7O4.C22H25F2N7O3.C21H24F2N8O2/c1-24(25,26)36-19-7-4-5-16(13-19)14-27-23(35)20-15-33(32-30-20)12-3-2-6-18-10-11-21(31-29-18)28-22(34)17-8-9-17;1-25-24(34)21-17-32(30-28-21)10-3-2-6-19-8-9-22(29-27-19)26-23(33)16-18-5-4-7-20(15-18)31-11-13-35-14-12-31;1-23(24,25)16-9-10-26-18(12-16)13-27-22(35)19-14-33(32-30-19)11-3-2-4-17-7-8-20(31-29-17)28-21(34)15-5-6-15;1-24-23(32)20-16-30(29-27-20)11-4-3-7-18-9-10-21(28-26-18)25-22(31)15-17-6-5-8-19(14-17)34-13-12-33-2;1-15(32)26-20-10-9-17(27-29-20)7-3-4-11-31-14-19(28-30-31)21(33)25-13-16-6-5-8-18(12-16)34-22(2,23)24;1-14(32)26-19-7-6-16(27-29-19)5-3-4-10-31-13-18(28-30-31)20(33)25-12-17-11-15(8-9-24-17)21(2,22)23/h4-5,7,10-11,13,15,17H,2-3,6,8-9,12,14H2,1H3,(H,27,35)(H,28,31,34);4-5,7-9,15,17H,2-3,6,10-14,16H2,1H3,(H,25,34)(H,26,29,33);7-10,12,14-15H,2-6,11,13H2,1H3,(H,27,35)(H,28,31,34);5-6,8-10,14,16H,3-4,7,11-13,15H2,1-2H3,(H,24,32)(H,25,28,31);5-6,8-10,12,14H,3-4,7,11,13H2,1-2H3,(H,25,33)(H,26,29,32);6-9,11,13H,3-5,10,12H2,1-2H3,(H,25,33)(H,26,29,32)
InChIKeyQZGZUZXCSDFCIH-UHFFFAOYSA-N
MW2862.08 g/mol
LogP14.82
Rot. Bonds67

About 1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide

1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide (PubChem CID 163919616) has the molecular formula C137H161F8N45O17 and a molecular weight of 2862.08 g/mol. Its IUPAC name is 1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide.

Molecular Properties

Compound Name1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide
PubChem CID163919616
Molecular FormulaC137H161F8N45O17
Molecular Weight2862.08 g/mol
Exact Mass2860.30
IUPAC Name1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide
SMILESCC(=O)Nc1ccc(CCCCn2cc(C(=O)NCc3cc(C(C)(F)F)ccn3)nn2)nn1.CC(=O)Nc1ccc(CCCCn2cc(C(=O)NCc3cccc(OC(C)(F)F)c3)nn2)nn1.CC(F)(F)Oc1cccc(CNC(=O)c2cn(CCCCc3ccc(NC(=O)C4CC4)nn3)nn2)c1.CC(F)(F)c1ccnc(CNC(=O)c2cn(CCCCc3ccc(NC(=O)C4CC4)nn3)nn2)c1.CNC(=O)c1cn(CCCCc2ccc(NC(=O)Cc3cccc(N4CCOCC4)c3)nn2)nn1.CNC(=O)c1cn(CCCCc2ccc(NC(=O)Cc3cccc(OCCOC)c3)nn2)nn1
InChIInChI=1S/C24H27F2N7O3.C24H30N8O3.C23H26F2N8O2.C23H29N7O4.C22H25F2N7O3.C21H24F2N8O2/c1-24(25,26)36-19-7-4-5-16(13-19)14-27-23(35)20-15-33(32-30-20)12-3-2-6-18-10-11-21(31-29-18)28-22(34)17-8-9-17;1-25-24(34)21-17-32(30-28-21)10-3-2-6-19-8-9-22(29-27-19)26-23(33)16-18-5-4-7-20(15-18)31-11-13-35-14-12-31;1-23(24,25)16-9-10-26-18(12-16)13-27-22(35)19-14-33(32-30-19)11-3-2-4-17-7-8-20(31-29-17)28-21(34)15-5-6-15;1-24-23(32)20-16-30(29-27-20)11-4-3-7-18-9-10-21(28-26-18)25-22(31)15-17-6-5-8-19(14-17)34-13-12-33-2;1-15(32)26-20-10-9-17(27-29-20)7-3-4-11-31-14-19(28-30-31)21(33)25-13-16-6-5-8-18(12-16)34-22(2,23)24;1-14(32)26-19-7-6-16(27-29-19)5-3-4-10-31-13-18(28-30-31)20(33)25-12-17-11-15(8-9-24-17)21(2,22)23/h4-5,7,10-11,13,15,17H,2-3,6,8-9,12,14H2,1H3,(H,27,35)(H,28,31,34);4-5,7-9,15,17H,2-3,6,10-14,16H2,1H3,(H,25,34)(H,26,29,33);7-10,12,14-15H,2-6,11,13H2,1H3,(H,27,35)(H,28,31,34);5-6,8-10,14,16H,3-4,7,11-13,15H2,1-2H3,(H,24,32)(H,25,28,31);5-6,8-10,12,14H,3-4,7,11,13H2,1-2H3,(H,25,33)(H,26,29,32);6-9,11,13H,3-5,10,12H2,1-2H3,(H,25,33)(H,26,29,32)
InChIKeyQZGZUZXCSDFCIH-UHFFFAOYSA-N
XLogP14.82
TPSA763.31 Ų
H-Bond Donors12
H-Bond Acceptors50
Rotatable Bonds67
Heavy Atoms207
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002862.08
LogP ≤ 514.82
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1050

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide?
The IUPAC name of 1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide (CID 163919616) is 1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide.
What is the SMILES notation for 1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide?
The canonical SMILES for 1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide is CC(=O)Nc1ccc(CCCCn2cc(C(=O)NCc3cc(C(C)(F)F)ccn3)nn2)nn1.CC(=O)Nc1ccc(CCCCn2cc(C(=O)NCc3cccc(OC(C)(F)F)c3)nn2)nn1.CC(F)(F)Oc1cccc(CNC(=O)c2cn(CCCCc3ccc(NC(=O)C4CC4)nn3)nn2)c1.CC(F)(F)c1ccnc(CNC(=O)c2cn(CCCCc3ccc(NC(=O)C4CC4)nn3)nn2)c1.CNC(=O)c1cn(CCCCc2ccc(NC(=O)Cc3cccc(N4CCOCC4)c3)nn2)nn1.CNC(=O)c1cn(CCCCc2ccc(NC(=O)Cc3cccc(OCCOC)c3)nn2)nn1.
What is the InChIKey of 1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide?
The InChIKey is QZGZUZXCSDFCIH-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H27F2N7O3.C24H30N8O3.C23H26F2N8O2.C23H29N7O4.C22H25F2N7O3.C21H24F2N8O2/c1-24(25,26)36-19-7-4-5-16(13-19)14-27-23(35)20-15-33(32-30-20)12-3-2-6-18-10-11-21(31-29-18)28-22(34)17-8-9-17;1-25-24(34)21-17-32(30-28-21)10-3-2-6-19-8-9-22(29-27-19)26-23(33)16-18-5-4-7-20(15-18)31-11-13-35-14-12-31;1-23(24,25)16-9-10-26-18(12-16)13-27-22(35)19-14-33(32-30-19)11-3-2-4-17-7-8-20(31-29-17)28-21(34)15-5-6-15;1-24-23(32)20-16-30(29-27-20)11-4-3-7-18-9-10-21(28-26-18)25-22(31)15-17-6-5-8-19(14-17)34-13-12-33-2;1-15(32)26-20-10-9-17(27-29-20)7-3-4-11-31-14-19(28-30-31)21(33)25-13-16-6-5-8-18(12-16)34-22(2,23)24;1-14(32)26-19-7-6-16(27-29-19)5-3-4-10-31-13-18(28-30-31)20(33)25-12-17-11-15(8-9-24-17)21(2,22)23/h4-5,7,10-11,13,15,17H,2-3,6,8-9,12,14H2,1H3,(H,27,35)(H,28,31,34);4-5,7-9,15,17H,2-3,6,10-14,16H2,1H3,(H,25,34)(H,26,29,33);7-10,12,14-15H,2-6,11,13H2,1H3,(H,27,35)(H,28,31,34);5-6,8-10,14,16H,3-4,7,11-13,15H2,1-2H3,(H,24,32)(H,25,28,31);5-6,8-10,12,14H,3-4,7,11,13H2,1-2H3,(H,25,33)(H,26,29,32);6-9,11,13H,3-5,10,12H2,1-2H3,(H,25,33)(H,26,29,32).
What are the key properties of 1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide?
1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide has a molecular weight of 2862.08 g/mol, XLogP of 14.82, 67 rotatable bonds, 12 hydrogen bond donors, and 50 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-(6-acetamidopyridazin-3-yl)butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[3-(1,1-difluoroethoxy)phenyl]methyl]triazole-4-carboxamide;1-[4-[6-(cyclopropanecarbonylamino)pyridazin-3-yl]butyl]-N-[[4-(1,1-difluoroethyl)-2-pyridinyl]methyl]triazole-4-carboxamide;1-[4-[6-[[2-[3-(2-methoxyethoxy)phenyl]acetyl]amino]pyridazin-3-yl]butyl]-N-methyltriazole-4-carboxamide;N-methyl-1-[4-[6-[[2-(3-morpholin-4-ylphenyl)acetyl]amino]pyridazin-3-yl]butyl]triazole-4-carboxamide is sourced from PubChem (CID 163919616), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).